RHEI Pharmaceuticals, which is focused on introducing approved and late clinical-stage proprietary drugs from the U.S. into China, announced today that Timothy M. Kish has joined the company as president and CFO.
Charles P. Slacik has resigned as CFO of Watson Pharmaceuticals to become senior vice president and chief financial officer of Beckman Coulter.
Robert J. Darretta is retiring as chief financial officer and vice chairman of the board in early 2007 after 38 years at the company.
Cardax Pharmaceuticals has appointed Fredric Pashkow, MD as executive vice president and chief medical officer.
Transave has hired Renu Gupta, M.D. as executive vice president of development and chief medical officer.
SuperGen announced that chief operating officer Edward Jacobs will leave the company at year-end.
Pharmos Corporation has named S. Colin Neill as senior vice president, chief financial officer, secretary and treasurer.
GenVec has hired Mark O. Thornton, MD, MPH, PhD as senior vice president, clinical development.
VioQuest Pharmaceuticals has named Lawrence Akinsanmi, M.D., Ph.D., to the role of vice president of clinical operations and regulatory affairs.
Array BioPharma has appointed April H. Teitelbaum, MD, MS, FACP, to the newly created position of vice president of clinical development--oncology.
Diatos SA has named Dr. Jamal Gasmi chief medical officer and Dr. James Cowburn as chief sales and marketing officer.
BioQuest LLC announced that Karen Skillen has joined the firm as managing director of its biopharmaceutical practice.
Penwest Pharmaceuticals announced that Amy O'Donnell, M.D. has joined the company as senior director, clinical development.
The life sciences venture firm Alta Partners announced that Alison de Bord has been promoted to director.
Progenitor Cell Therapy announced that Robert Hamm and Professor K.K. Jain have both agreed to join its board of managers.
The appointment of Maria Borelius as the Minister of Trade for Sweden has led to her resignation from the board of Active Biotech.
Joseph P. Cooper has joined Bioenvision's board of directors.
Rigel Pharmaceuticals has appointed Gary Lyons, an existing board member, to the audit committee.
Stem Cell Sciences has named David A. Dodd a non-executive director.
Affymax has named Daniel K. Spiegelman to its board of directors.
NovaVision named John F. Sasen, Sr. to its board of directors.
Peter O'Callaghan, senior vice president at QLT, and Dr. Simon Pimstone, CEO at Xenon Pharmaceuticals, were elected to BC Biotech's board of directors.
NanoBio has named Ronald M. Cresswell, Ph.D., Hon. D. Sc., F.R.S.E., to its board of directors.